Heidelberg Pharma AG
XETRA:HPHA
Heidelberg Pharma AG
XETRA:HPHA
Price:
3.04
EUR
0.33%
Market Closed
Market Cap:
€142.2m
Wall Street
Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
Heidelberg Pharma AG
Wall Street analysts forecast HPHA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
HPHA
is 5.61 EUR
with a low forecast of 5.56 EUR and a high forecast of 5.78 EUR.
Lowest
Price Target
5.56
EUR
83% Upside
Average
Price Target
5.61
EUR
85% Upside
Highest
Price Target
5.78
EUR
90% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HPHA's stock price target?
Price Target
5.61
EUR
5.61
EUR
According to Wall Street analysts, the average 1-year price target for
HPHA
is 5.61 EUR
with a low forecast of 5.56 EUR and a high forecast of 5.78 EUR.
What is Heidelberg Pharma AG's Revenue forecast?
Projected CAGR
25%
25%
For the last 8 years the
compound annual growth rate for
Heidelberg Pharma AG's revenue is
22%.
The projected
CAGR
for the next 3 years is
25%.
